Southern Star Research
Daniel Evans is the Director of Business Development at Southern Star Research, a full-service Clinical Research Organisation with experience in early Phase clinical studies for the Biotechnology, Pharmaceutical, and Medical Device Sectors. Prior to this role, Daniel held positions such as Chief Business Development Officer and Global Head of Business Development at a Start Up CRO. Daniel also served as a Partner at Proclinical Executive and as a Client Services Director at Proclinical Group. Daniel began their career as an Account Executive at Tungate Group and holds a BA (Hons) in Business Studies and Management from Sheffield Hallam University.
This person is not in any teams
Southern Star Research
Sydney-based CRO Southern Star Research can access the financial, operational and regulatory advantages of conducting clinical trials in Australia. This local knowledge, as well as our full-service offering, enables our biotechnology, pharmaceutical and medical device customers to benefit from the Australian environment. We have expertise in a broad range of indications, and a Clinical Team who have an average of 17 years direct clinical research experience. Furthermore, all of our work is underpinned by a passion for cutting edge science, a keen interest in early stage clinical development and a willingness to provide every client with exceptional customer service. With a track record of success in clinical trials spanning Phase I to IV, Southern Star Research has both the capability and the drive to support your R&D objectives in Australia and Asia-Pacific.